Examples of using Cellcept in English and their translations into German
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Ecclesiastic
-
Political
-
Computer
-
Programming
-
Official/political
-
Political
Other ingredients of CellCept.
If too much CellCept IV solution is given.
Or any of the other ingredients of CellCept.
CellCept has not been shown to impair your ability to drive or operate machinery.
This means that Myfenax is similar to a‘ reference medicine' already authorisedin the European Union(EU) called CellCept.
Main growth drivers are the Group's five leading oncology medicines,plus key products CellCept and Bonviva/Boniva- all with double-digit increases.
If you answer yes to any of the followingquestions talk to your doctor before you start to take CellCept.
Effective contraception must be used before beginning CellCept therapy, during therapy, and for six weeks following discontinuation of therapy see section 4.5.
Because mycophenolate mofetil has demonstrated teratogenic effects in rats andrabbits, CellCept tablets should not be crushed.
Mycophenolate mofetil(CellCept®, MMF) is a potent immunosuppressant that inhibits the proliferation of T and B lymphocytes by blocking the synthesis of purine nucleotides.
Because mycophenolate mofetil has demonstrated teratogenic effects in rats andrabbits, CellCept capsules should not be opened or crushed.
Negative impacts included expected decreases in sales of Tamiflu, Avastin(metastatic breast cancer indication), NeoRecormon/Epogin,Bonviva/Boniva and CellCept.
CellCept(mycophenolate mofetil) is the world's most widely used immunosuppressant medication and the cornerstone of treatment to prevent organ rejection in patients with solid organ transplants.
As evidenced by suppression of acute rejection following renal transplantation,the immunosuppressant activity of CellCept is correlated with MPA concentration.
The immunosuppressant CellCept(mycophenolate mofetil) continued to record steady sales growth worldwide(8%), driven by solid sales in both the US and Europe.
Because Myfenax is a generic medicine, studies in patients have been limited to tests todetermine that it is bioequivalent to the reference medicine, CellCept.
CellCept capsules should be handled with care Do not open or crush the capsules and breathe the powder inside the capsules or allow it to touch your skin.
Other pharmaceuticals driving growth included Bonviva/Boniva for osteoporosis, CellCept in transplantation, Pegasys in virology and the ophthalmology medicine Lucentis.
With the potential to use CellCept and daclizumab s.c. as the centerpiece for long-term transplant therapy, we could offer patients a safer, more tolerable option.”.
In July 2003, Aspreva signed a collaboration agreement with Roche for the exclusive worldwide rights(excluding Japan) to develop and, upon regulatory approval,commercialise CellCept for all autoimmune disease applications.
Patients should be advised that during treatment with CellCept, vaccinations may be less effective and the use of live attenuated vaccines should be avoided see section 4.5.
CellCept was compared with azathioprine(another anti-rejection medicine) in all studies except for one of the kidney transplant studies, in which it was compared with placebo a dummy treatment.
Your doctor should advise you about using contraception before treatment with CellCept is started, during treatment with CellCept, and for 6 weeks after you have stopped treatment with CellCept.
You must not use CellCept during pregnancy unless clearly indicated by your doctor. Your doctor should advise you about using contraception before taking CellCept, whilst taking CellCept, and for 6 weeks after you have stopped taking CellCept.
In children undergoing kidney transplants, the rejection rates were similar to those seen in adults taking CellCept and lower than those seen in other studies of children who did not receive CellCept.
The immunosuppressant CellCept(mycophenolate mofetil), for the prevention of transplant rejection, maintained its sales growth worldwide and remains the top-selling branded immunosuppressant in the US.
In view of the significant reduction in the AUC of MPA by cholestyramine, caution should be used in the concomitant administration of CellCept with medicinal products that interfere with enterohepatic recirculation because of the potential to reduce the efficacy of CellCept.
Because CellCept has been associated with an increased incidence of digestive system adverse events, including infrequent cases of gastrointestinal tract ulceration, haemorrhage and perforation, CellCept should be administered with caution in patients with active serious digestive system disease.
Monitoring MPA, the active form of Roche's leading immunosuppreseant CellCept, enables physicians to maintain adequate immunosuppression at critical time points such as when initiating therapy or when reducing other, more toxic anti-rejection drugs.
